Organization Profile

You just read:

Health Canada Approves PLEGRIDY™ (peginterferon beta-1a) for Adults with Relapsing Remitting Multiple Sclerosis

News provided by

Biogen Canada Inc.

Aug 13, 2015, 08:00 ET